Waters Corporation, based in Milford, Massachusetts, provides analytical workflow solutions with a market cap of $21 billion. Expected to announce fiscal second-quarter earnings on August 4, analysts predict a profit of $2.92 per share, up 11% from the year-ago quarter. Full-year EPS expected to rise to $12.90.

WAT stock has outperformed the S&P 500 and Health Care Select Sector SPDR Fund over the past 52 weeks, with shares up 17.1%. Impressive performance linked to success in pharmaceutical markets and strong growth in instrument sales. On May 6, shares closed down after reporting Q1 results, beating Wall Street expectations.

Analysts hold a reasonably bullish outlook on WAT stock, with a “Moderate Buy” rating overall. Out of 18 analysts, seven recommend a “Strong Buy” and 11 suggest a “Hold.” Average analyst price target is $394.11, indicating a potential upside of 11.7% from current levels. No positions held by Neha Panjwani.

Read more at Yahoo Finance: What to Expect From Waters Corporation’s Next Quarterly Earnings Report